Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14706-14716
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14706
Table 1 Multiple linear regressions to body mass index and homeostasis model assessment
rr2r2changeFSigβP-value
BMI0.6670.4450.44517.842< 0.0001
Waist/hip ratio-0.0130.841
FM,%0.1050.084
Total cholesterol, mg/dL0.1480.039
HDL cholesterol, mg/dL-0.0880.259
Triglycerides, mg/dL-0.1030.184
HOMA0.564< 0.0001
ADV36 seropositivity0.1820.004
HOMA0.6710.4510.45118.285< 0.0001
Waist/hip ratio-0.0550.389
BMI, kg/m20.558< 0.0001
FM, %-0.0320.598
Total cholesterol, mg/dL0.0040.956
HDL cholesterol, mg/dL-0.1020.188
Triglycerides, mg/dL0.2130.006
ADV36 seropositivity0.0050.938
Table 2 Multiple Linear regression to non-alcoholic fatty liver disease-ADV37 seropositivity
NAFLD
rr2FSigβP-value
0.6320.418.789< 0.0001
ADV37 seropositivity0.2220.001
HDL cholesterol, mg/dL0.0970.190
Triglycerides, mg/dL0.1330.073
HOMA-0.0520.572
BMI, kg/m2-0.557< 0.0001
Table 3 Multiple linear regression, body mass index balanced, to non-alcoholic fatty liver disease disappearance - effects of changes
All patients (n = 62)
rr2FSigβP-value
0.6350.4032.7010.029
ADV36 seropositivity0.4080.013
Waist/hip ratio0.0180.907
ΔWeight, kg0.4130.057
ΔFM,%0.4330.012
ΔHOMA0.1890.284
ΔALT, U/L0.2790.095
ΔLongitudinal right liver (mm)-0.1540.386